Bioactive rather than total IGF-I is involved in acute responses to nutritional interventions in CAPD patients
- PMID: 19903658
- DOI: 10.1093/ndt/gfp576
Bioactive rather than total IGF-I is involved in acute responses to nutritional interventions in CAPD patients
Abstract
Background: Inadequate food intake plays an important role in the development of malnutrition in continuous ambulatory peritoneal dialysis (CAPD) patients. Aim of the study. The aim of the study was to investigate in CAPD patients whether circulating insulin-like growth factor-I (IGF-I) bioactivity may offer a more sensitive index to acute nutritional interventions than total IGF-I.
Methods: An open-label, randomized, crossover study of 2 days-with a 1-week interval-was performed in 12 CAPD patients in the fed state to compare a mixture of amino acids (Nutrineal 1.1%) plus glucose (AA plus G) (Physioneal 1.36% to 3.86%) dialysate versus G only as control dialysate. Fed-state conditions were created by identical liquid hourly meals. IGF-I bioactivity was measured by the kinase receptor activation assay (IGF-I KIRA); total IGF-I was measured by immunoassay.
Results: In the fed state, both after AA plus G as well as after G dialysis IGF-I bioactivity increased compared to baseline, while no changes in circulating total IGF-I levels were observed in both treatment arms. However, the increase in IGF-I bioactivity was only significant after AA plus G dialysis (P = 0.02).
Conclusions: Our results provide evidence that in CAPD patients changes in circulating IGF-I bioactivity are associated with nutrient intake and that IGF-I bioactivity rather than total IGF-I is involved in acute responses to nutritional interventions in CAPD patients.
Similar articles
-
Peritoneal dialysis with solutions containing amino acids plus glucose promotes protein synthesis during oral feeding.Clin J Am Soc Nephrol. 2007 Jan;2(1):74-80. doi: 10.2215/CJN.01370406. Epub 2006 Nov 8. Clin J Am Soc Nephrol. 2007. PMID: 17699390 Clinical Trial.
-
Dialysate as food: combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis.J Am Soc Nephrol. 2005 May;16(5):1486-93. doi: 10.1681/ASN.2004050402. Epub 2005 Mar 30. J Am Soc Nephrol. 2005. PMID: 15800130 Clinical Trial.
-
Impact of dialysis duration and glucose absorption on nutritional indices in stable continuous ambulatory peritoneal dialysis patients.J Ren Nutr. 2008 Nov;18(6):503-8. doi: 10.1053/j.jrn.2008.06.002. J Ren Nutr. 2008. PMID: 18940653
-
Protein and amino acid metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).Clin Nephrol. 1988;30 Suppl 1:S59-63. Clin Nephrol. 1988. PMID: 3141094 Review.
-
New insight of amino acid-based dialysis solutions.Kidney Int Suppl. 2006 Nov;(103):S110-4. doi: 10.1038/sj.ki.5001925. Kidney Int Suppl. 2006. PMID: 17080099 Review.
Cited by
-
Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover study.BMC Nephrol. 2013 Apr 4;14:80. doi: 10.1186/1471-2369-14-80. BMC Nephrol. 2013. PMID: 23557110 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical